Hello All PPHM shareholders. I haven't spoken to the shareholders in a while. I took my sack off the Rack on the run up to 0.59 a couple months ago. Like CARBOAT, I am astounded that the head of drug development has not spoken to shareholders or at least said a few things to us bagholders to earn his keep. I may put another sack on the Rack if we retest the 0.33 low of a few weeks ago. I am concerned about a reverse split so I am keeping the Jack in my backpack for now.

ALL THE BEST
NEW HORIZON

What a great year ahead; 2016 will be a year in which the future destiny of PPHM will be determined. I am excited, so is GARNICK, Couch, and most all the LONGS on this board. I am thankful to have this opportunity. It's an opportunity I would not miss for the world. I have multiple puts (which I sold with FE strikes) which will expire on Friday (2-19). If PPHM shares are still range bound the week ending 2-26 will be a feast. Over the next few weeks I believe it is time to get serious about adding to my current PPHM holdings. Once we are approved for 2nd Line NSCLC the floodgates will swing open and within five years Bavi will be approved for multiple Indications. I'm so excited. Next.

ALL THE BEST
GULL

Thanks CVB. Since we reached full enrollment on 2-1-16 the next catalyst up will be the first Look-in. Shortly we will be getting the results of the 1st look-in which hopefully will elevate the PPS and assist PPHM in raising additional funds which will be required before the BAVITUXIMAB Launch. Remember CHTP @ 0.80 just before their staircase to $6.50. PPHM is next up. Don't be left behind.

ALL THE BEST
TK

Well stated. We will be getting a full enrollment PR soon. The first lookin before the end of the first quarter is drawing near. There has never been a better time to be a PPHM shareholder. NSCLC is either the #1 or #2 cancer that has been fatal to cancer patients around the Globe. BAVI will be in big demand soon,

ALL THE BEST
TK

Stocks that are going to go much higher usually go much lower just before the big Ascent begins.

ALL THE BEST
TK

No one ever makes JACK (money) being negative. The one common thread to all successful investors is that they are all OPTIMISTS.
That being said, one has to keep his eye on the prize. Any negativity can prevent him/her from having access to that prize. It is true that optimists will still have an occasional EGO SPASM but the EUPHORIA with success will make that SPASM minute (small).

ALL THE BEST
GULL

I bought DNDN after it had descended from $55.00 down to about $8.00. I held the shares when it made it's final ascent to $17.05. After it collapsed and went back below my entry price I finally exited the shares at about $6.75. The loss was a little over 10% but I was forever kicking myself for at least not selling half my shares when the PPS had more than doubled. As Cramer said; pigs get slaughtered, so it is never good to be too greedy. Discipline is a must when you are investing in Biotech's.

ALL THE BEST
GULL

What the Hedge Funds did to DNDN in DEEP CAPTURE was to make business so expensive that they would eventually have to capitulate. Even on a day when there was good news they would drive the PPS down by NAKED SHORTING. A big difference here is that DNDN did not have a SKIPPER with the expertise of DR GARNICK. They have put up a DAM that has blocked commerce for a period of time but there will soon be a rupture and the DAM will be permanently washed away. For he that has wisdom; can you imagine (AFTER BAVI IS APPROVED) how easy it will be to carry out all the trials involving BAVI with other Immunotherapies once the money begins to flow from the GLOBAL SALES of BAVI. Those with a five year time horizon should be quite happy with their PPHM investment. On average it takes Ten years to bring a drug to market. We are almost there.

ALL THE BEST
GULL

Well said CP. This is definitely the best quarter ever. All PPHM shareholders should be smiling today. Thanks so much for all that you, BIOPHARM, CJ, and MD do to make the PPHM board the best.

ALL THE BEST
GULL

I expect DART to buy more in the coming months. That is a signal that everyone should be doing the same. We are no longer in the dark in regards to Sunrise. We were given the numbers today. The time has passed that anyone should be selling any shares in PPHM. Don't give your cheap shares away to anyone. If you want, they will pay you big bucks later, but I still would not let them have the shares.

ALL THE BEST
GULL

This is the first time they have given us any number in relation to the Phase III enrollment in Sunrise. Enrollment of over 90% stipulates that there are over 524 patients currently enrolled. DR GARNICK said that we had reached all the numbers that are required for the first Look-in that should occur in the first quarter. The rapid growth in AVID Revenues is a big plus for PPHM going forward. The rapid pace at which PPHM is originating new trials with BAVI in combination with other immunotherapies speaks volumes as to the confidence that DR GARNICK has in the SUNRISE Trial. Everything is going as to DR GARNICK'S original plan. Be patient. We are almost there.

ALL THE BEST
GULL

Our thoughts and prayers are with you. Stay strong and think positive. We love you.

ALL THE BEST
GULL

I have had TPIV on my radar for quite some time. My goal was to buy a substantial position in it below $0.50. I was involved in selling the $18.00 Strike (PUT) and the $21.00 Strike (PUT) in the November Expiration in HZNP, along with selling the $9.00 and $10.00 strike (PUT) in MACK in the November expiration. In the meantime, TPIV did breach the $0.50 price and I missed a great buy because I had it on a separate list (SCOTTRADE STREAMING QUOTES) and did not check on it in that timeframe. I did collect the premium on the HZNP $18.00 strike (PUT) but I was exercised and bought more HNP shares @ the $21.00 Strike (PUT). Good news, from the premium that I collected from the $18.00 strike (PUT), my actual entry price after being exercised at the $21.00 strike was below $14.00. The bad news was that I became too involved on other things and missed a historic trade on TPIV below $0.50. When they get that cheap you have to pull the trigger because KEN DART owns a large stake in TPIV for a reason. The good news is that I did not sell any of my PPHM on the latest move above the 200 day moving average. As North said, PPHM and AMRN have catalysts that could greatly appreciate their PPS so the password here is patience.

ALL THE BEST
GULL

Thanks CP. DR GARNICK spoke highly of CONTARA when he first arrived at PPHM in 2008. The Protocol is to get Bavituximab approved first and then he will most likely authorize the phase III trial for CONTARA. After Bavi is approved in the Sunrise trial, I am sure there will be a couple dozen combination trials launched immediately involving Bavi in combination with the best immunotherapies that have been proven to date. The gates will open up when Bavi is approved in the Sunrise trial. That will be equivalent to the bursting of the Dam; the flood will come and instead of picking up money off the ground ( That's what we are doing with the opportunity we have today at these Depressed prices) It will be falling from the sky. Which one is better; I am not going to argue with anyone on that point.

ALL THE BEST
GULL

The increased volume on today's uptick which was almost twice the volume of the two previous upticks (the intraday move up to $1.28) spells volume as to the future movement of the PPS. Today's volume of approximately 3.6 million says that the PPS should be going higher tomorrow (Volume precedes price). I know we all got caught flat footed on the big move in KBIO. I was watching and would have probably made a purchase if it had spent a little more time at $0.45. A move TO $45.82 was a 100 bagger (10,000 percent) so I was too much involved with PPHM, EXEL, MACK, and HZNP to pay the needed attention to get on that train. December should be an awesome month for PPHM. This is the best GOLDEN GEM in all of the stock market. Good things come to those who wait.

ALL THE BEST
GULL

Seagull2- 12/31/15 = $1.42 6/30/16= $1.85 6/30/17= $27.89

It's a rare occasion that someone has the opportunity to buy a GOLDEN GEM at such extremely cheap prices. And to have such an experienced skipper at the Helm makes it a no-brainer. DR GARNICK believes that BAVITUXIMAB will not have the phase III problems that many other companies have with their drugs in phase III. How do I know this; He said so. AS HORSELOVER (Andy) said, he is very confidant in the success of BAVI. And so am I.

ALL THE BEST
GULL

I think that he does own the preferred shares also. From my best recollection he owned almost Ten million of the common before he made his last purchase at $1.08 with the 18,588,000 purchase. He has a net worth of 6.8 Billion so this is pocket change to him.

ALL THE BEST
GULL

Thanks ENDO. I believe that Dart, with this purchase now owns almost 30 million shares. He is by far the largest Institutional owner of PPHM shares.

ALL THE BEST
GULL

Thanks HUTSCHI. Eastern Capital buying almost Nineteen Million Shares @ $1.08 with no with all proceeds going to PPHM ($20,000,000.00) showed that Eastern is quite wise and will most likely become the new BILLIONAIRE on the block. This transaction should now make $1.08 the new support in a pullback so the pullback we have seen from $1.17 has probably just about run it's course. This transaction should also raise the Institutional Ownership to over 20%. This may also signal that Eastern knows something already that the rest of us will know soon. I believe that Eastern has seen behind the Curtain and was amazed at what they saw. GLTAL.

ALL THE BEST
GULL

The announcement of full enrollment would definitely enlighten wall street to Peregrine. A small company (PPHM) that owns and controls the complete supply chain (manufacturing and distribution) would defy the laws of gravity once the faucet begins to drip. If the faucet is turned on (Katy bar the door); the PPS of PPHM could double very quickly and those left chasing the bid would suffer a massive EGO SPASM. ELTP has a pain drug that if approved would most likely face the same challenges that ZGNX did with ZOHYDRO. With the PPS of ELTF selling so cheap it would be nice if you had picked up a nice position in the 0.25-0.30 range. Biotechs in general have had a nice bear market. The 50% retracement rule says that the next two months could pay dividends to those who took advantage.

ALL THE BEST
GULL

We are nearing the time that many CATLYSTS are coming due in this GOLDEN GEM. The next couple months should be very exciting. It's a shame that they aren't offering me a premium on the front month $1 put. I did take advantage on the VRX November 85 put. I made a nice return Thursday on the 85 put but did not get a fill Friday on the November 65 put @ $6.00. Back to PPHM, our time is very near. Amazing times are coming soon.

ALL THE BEST
MR GULL

PPHM will have to raise much more capital before they receive FDA approval for BAVITUXIMAB. Whether that comes from issuing shares or from a BP, it is crucial that they do that in the intermediate term. The FDA will look at PPHM'S assets, manufacturing capacity and the tremendous improvement in MOS that BAVI brings and they will send DR GARNICK a letter saying BAVITUXIMAB has been approved for commercialization. Hopefully they can publish a PR from either MSK or AZN that can give the PPHM PPS a nice boost before they do a large dilution. Either way, we are in a race; there are multiple combinations that are being approved by the FDA in this space, so hopefully we can still get a large share of this market after approval 14 months from now. If our combination numbers are great we can still dominate this space.

ALL THE BEST
GULL

IN one day AQXP went from $1.34 to $55.00 per share. I missed this one entirely but they don't have a ROB GARNICK. Such is the nature with a BIOTECH GOLDEN GEM. Once the FAUCET is turned on all laws of GRAVITY will be ignored and we will be on our mission. It is a must that PPHM must protect what we have with complete secrecy because to be successful we have to be able to carry what we have to the finish line. Owning the COMPLETE SUPPLY CHAIN, the manufacturing and distribution of their pipeline is a luxury that PPHM has that most small Biotech's don't have. The future awaits.

ALL THE BEST
GULL

FDA looked at the SALVAGED DATA and gave us FAST TRACK DESIGNATION from which we have THE SUNRISE PHASE III TRIAL. If you look at all matters from a CONTRARIAN point of view, maybe all investors who did not drink the COOLAIDE and keep the faith when all the DIATRIBES were being hurled at PPHM will be highly rewarded when this GOLDEN GEM GETS IT'S DAY IN THE SUN. Each day we are rewarded another chance to own this GOLDEN GEM at discounted prices. It is time for all to take off the visors and enjoy the moment. An amazing opportunity has been presented to us on a SILVER PLATTER.

ALL THE BEST
GULL

But you do want to accumulate THIS GOLDEN GEM and be ready to celebrate when the confirmation comes and the HELIUM in this ballon will rise and rise and rise. With all the recent partnerships that PPHM has entered into it is obvious that others are beginning to see the light and the sun still hasn't risen yet. My advice to all is to get aboard, take a seat, smile from ear to ear, and feel awesome that we know what we know and had all this time to get some cheap shares of a soon to be GOLDEN GEM. The future awaits.

ALL THE BEST
GULL

The gap up by EXEL on July 20 was quite rewarding to Exel shareholders. I have held EXEL since the time they first sank below $4.00 a year or two ago. I bought again when it went below $2.00 and again when it went below $1.50. I sold my whole position in the Premarket on 7/20 for $6.43 and bought the entire position back later that day for $5.48. Holding Long and strong in EXEL. I think there is a good chance it will double from existing prices by the end of the year. Like PPHM we just have to buy them and hold them when they are cheap. When the move in PPHM comes, as it was in EXEL a triple In PPS in a short period of time will be the norm. Buying the options on HZNP along with the shares has been quite rewarding also. The options will be active on PPHM once they break out of the current price channel. At that time it may be beneficial to sell some puts if the premiums are large enough both in and out of the money . I did that with EXEL when it was moving up; collecting premiums months on strikes well below the PPS.

ALL THE BEST
GULL

An all stock acquisition of DEPO by HZNP should create a PPS for HZNP that is on steroids if it is successful. An additional six new drugs with current annual sales of $400,000,000.00 added to HZNP'S seven current drugs at no monetary cost (only share dilution to shareholders) should create a market cap for the combined company of well over Ten Billion. It appears that Mr Walbert is working overtime for HZNP shareholders.

ALL THE BEST
GULL

Sounds like a lot of BUMPS IN THE ROAD. What we need to do is: LOOK STRAIGHT AHEAD THERE'S NOTHING BUT BLUE SKIES, LOOK ALL AROUND, NOTHING BUT BLUE SKIES. The sky is blue and better days are coming for those who are patient. As MD said; A bird in the hand is worth three in the bush. Too many people are focusing on PPS. PPHM today has more true value than several companies that are trading above $100.00 per share. When the SPIGOT begins to drip; LOOK OUT.

ALL THE BEST
GULL

It was green today because it's clinical results beat by 42% the current standard of care (AFINITOR) That was the reason that large buyers were buying in at the close at $6.31. EXEL could easily go to $20.00 if Cometrig is approved on November 11. Volume precedes price.

ALL THE BEST
GULL

If I were you I would cover that short immediately. We may not even trade at $5.88 again. I sold the $6.00 call on Monday and covered it today for 0.25 more than what I sold it for so I could keep my shares. This was offset by selling my shares in the premarket @ $6.42 on Monday and buying them back later at $5.49. I was confident that the Issue price would be much lower than $5.88 but today's PPS action convinced me otherwise so I paid 0.65 for the calls that I sold for 0.40. I did sell the $7.00 strike on 1/3 of my shares today, mostly to get back the 0.25 that I surrendered on the $6.00 strike. On July's option expiration I sold the $5.00 strike and was fortunate that they waited till Monday to issue the good news. EXEL should steadily move higher after the underwriters complete their offering. It will be trading a dollar above the offering price when the underwriters purchase the additional three million shares.

ALL THE BEST
GULL

If the underwriters do the deal at $5.88 that will be very bullish for investors. I believe the underwriters will buy the additional three million shares which means we could be trading a buck or two above the price where the underwriters purchase the shares in a few weeks. Higher prices are ahead for EXEL. This could be the best Biotech to own for the rest of the year.

ALL THE BEST
GULL

Well said Couch. GARNICK has his stock options and he will be extremely rewarded. Time is of the essence here. More time means more time to accumulate. No one has an excuse if they fail to see the light.

ALL THE BEST
GULL

But EXELIS Cometrig badly beat the results from the BMY sponsored and FDA approved drug (AFINITOR). So EXELIS is in a sweet spot for the rest of this year. Their cash position is dismal which will probably weaken and restrain the PPS until they issue more shares and raise cash. Just like PPHM, but I think the upside potential in their shares is awesome after they complete their underwriting.

ALL THE BEST
GULL

Most companies sell shares to raise cash before they have their drugs Approved. It's only normal for them to take advantage of good news to improve their finances. Also the FDA likes to see that a company has stable finances before they will approve a drug. EXEL will be raising cash to prepare for their PDUFA date with the FDA on November 11. The underwriters always like about a 20% discount to their highest close to do the deal. After Exel gets their finances up to date the upside potential of the PPS will be greatly enhanced.

ALL THE BEST
GULL

I would think that EXEL will be selling shares to raise capital later this week. My guess would be @ $4.75 per share. I think the PPS will begin to move up after the conclusion of the capital raise. It appears we have good support at the $4.30-$4.50 area. Twenty Million shares at $4.75 would bring in $95,000,000 which should carry the company thru the approval process of their two main indications which should be accomplished in the fourth quarter and first three quarters of 2016.


All THE BEST
GULL

Looking to add on any break above resistance at $4.18. Hoping to see $4.50 plus within the next two weeks. Motley fool says buy and hold this one. Don't be late to the party.

ALL THE BEST
GULL

The all time low will most likely be tested and broken. Since they have abandoned their lead drug clinical trials this means CLDN will have to meander a while in the wilderness. Book Value based on Stock offerings at much higher prices is not relative now since CLDN has no revenue and cash burn will continue to deplete the cash on hand which is why I believe you will be able to purchase these shares within the next three months for $0.80 or less. I believe it will hit those levels before the company brings a positive PR which will indicate an intermediate term bottom has been made.

ALL THE BEST
GULL

The cash on hand to pay shareholders I believe was a little over a dollar per share. Those are current numbers which will be depleted as they do their quarterly cash burn. So it appears to me that there will be an opportunity to buy CLDN in the $0.70-$0.85 channel since it has no catalysts of major significance in the intermediate term.

ALL THE BEST
GULL

What the management is doing with CLDN is similar to what management did with GNVC. In GNVC'S case, management came out and said that it was in the best interest of the shareholders that they dissolve the company and the PPS crashed to under a $1.00. About four weeks later they came out and posted the same PR gain that it was in the best interest of shareholders to dissolve the company Actually this was about the third time they had posted this PR, but after the third time you could buy the shares, early in the day for about $0.40. After about five weeks the shares eventually fell to $0.25 (where I had my buy waiting) but quickly jumped back up to the 0.27-0.28 area. After trading in the 0.25-0.31 range for a couple weeks the company came out and stated that they had decided not to dissolve the company and that they were hiring a new CEO. The stock price quickly ran to the 0.65 area and after a few days doubled again to a high of $1.35. To make a long story short, in less than six months the PPS of GNVC was trading above $4.00. Since we were first hit by a management PR on Friday, I am sure they will be another. It may now be that the company wants our shares so patience here can probably reap some huge rewards. But another purchase at or slightly above $1.00 will be okay, but the big purchase should be made after the next company PR and the next collapse of the PPS which I think will get the PPS down to $0.80. At this point you have to buy big because the resulting rally should double the PPS to around the $1.60 area which would be a huge return for those who showed patience.

ALL THE BEST
GULL